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Abstract
Background: Hypoxia in cancers results in the upregulation of hypoxia inducible factor 1 (HIF-1) and a microRNA, hsa-miR-
210 (miR-210) which is associated with a poor prognosis.
Methods and Findings: In human cancer cell lines and tumours, we found that miR-210 targets the mitochondrial iron
sulfur scaffold protein ISCU, required for assembly of iron-sulfur clusters, cofactors for key enzymes involved in the Krebs
cycle, electron transport, and iron metabolism. Down regulation of ISCU was the major cause of induction of reactive
oxygen species (ROS) in hypoxia. ISCU suppression reduced mitochondrial complex 1 activity and aconitase activity, caused
a shift to glycolysis in normoxia and enhanced cell survival. Cancers with low ISCU had a worse prognosis.
Conclusions: Induction of these major hallmarks of cancer show that a single microRNA, miR-210, mediates a new
mechanism of adaptation to hypoxia, by regulating mitochondrial function via iron-sulfur cluster metabolism and free
radical generation.
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Introduction
Hypoxia is a major physiological difference between tumours
and normal tissue, mainly generated by tumour growth with
inadequate blood supply and consumption of oxygen by tumour
cells [reviewed in [1]]. Hypoxia induces a complex transcriptional
response mainly via induction of hypoxia inducible factor 1a
(HIF1a), affecting many biological processes such as the glycolytic
pathway, angiogenesis, pH regulation, invasion and immortalisa-
tion [2].
An emerging paradigm in hypoxia is that mitochondria produce
reactive oxygen species, mediated by electron transport continuing
in hypoxia [3]. This free radical pathway contributes to
upregulation of HIF [4] and enhanced growth in vivo [5], yet
may also be toxic. A variety of pathways induced by HIF have
already been reported to protect from the latter effect, for example
induction of pyruvate dehydrogenase kinase inhibits the enzyme
complex of pyruvate dehydrogenase and blocking the conversion
of pyruvate to acetyl coenzyme A, the first step in the Krebs cycle
[6] and enhances lactate production [7]. Mitophagy can be
induced by the BH3 domain protein BNIP3, [8], and cytochrome
C oxidase subunits may switch to more efficient ones [9].
Recently microRNAs (miRs), which are small (,22 nt) non-
coding RNAs that regulate post-transcriptional gene expression by
blocking translation of target mRNAs or by accelerating their
degradation [10,11], have been reported to be induced by
hypoxia. However, few of their targets or mechanisms of action
are known [reviewed in [12]]. We and others [13] have shown
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miR-210 is robustly induced by hypoxia in many cell lines, via
HIF1a [14]. We recently analysed its expression in a series of 216
breast cancer patients and showed miR-210 expression was
correlated with many HIF1a targets at mRNA level (as measured
by a hypoxia metagene) and was strongly associated with poor
patient survival. Derived only from sequence-based algorithms,
some of the previously validated targets of miR-210 include
Ephrin A3 [15], E2F3 [16], RAD52 [17], CASP8AP2 [18], and
MNT [19]. We combined publically available algorithms, with our
gene array datasets, to predict potential miR targets of importance
in cancer cells. We found that the mitochondrial iron sulfur cluster
homologue ISCU was the highest predicted target for miR-210.
Recently, ISCU has been identified as a miR-210 target also in
normal pulmonary endothelial cells [20], where it contributes to
the Pasteur effect and controls the level of ROS production in
hypoxia, suggesting its potential adaptive role to hypoxia in the
context of pulmonary endothelium.
Iron sulfur clusters [Fe-S] are present in the active sites of many
enzymes and proteins, critical for their activity and capable of
conferring regulation by redox status [21]. These clusters are
assembled in mitochondria [22] by a complex series of chaperones
and enzymes including ISCU, then exported to the cytoplasm,
where they are assembled into the relevant protein [23]. Amongst
the Fe-S cluster proteins involved are several that comprise key
components of complex I, II and III in the mitochondria, and
components of the Krebs cycle such as succinate dehydrogenase
and aconitase. The cytoplasmic form of the latter regulates iron
metabolism via its function as a translational regulator-IRP1 [24].
In this report we show the major biological effects of miR-210
targeting ISCU, all of which are likely to contribute to important
phenotypes in cancer. By downregulating ISCU, miR-210
decreases Krebs cycle enzyme activity and mitochondrial function,
provides a major mechanism for the increased free radical
generation in hypoxia, increases cell survival under hypoxia,
induces a switch to glycolysis in normoxia and hypoxia (Warburg
and Pasteur effects) and upregulation of the iron uptake required
for cell growth. Importantly, analysis of over 900 patients with
different tumour types showed that suppression of ISCU is
strongly correlated with a worse prognosis. This study thus reveals
a new pathway activated in hypoxic tumours, mediated by miR-
210 affecting mitochondrial enzyme activity and free radical
generation and highlights the importance of mitochondrial
metabolism in hypoxia biology [3].
Results
Selection of ISCU as a potential target
We compared miR-210 expression in our published series of
breast cancer [14] with our hypoxia metagene of clustered
mRNAs [25] and combined assessment with target prediction
algorithms showed ISCU was the highest predicted target, and
three known target genes also sit in highly-ranked positions were
selected by this approach (Supporting Material and Methods S1,
Supporting Table S1).
MiR-210 and ISCU mRNA undergo reciprocal regulation
In agreement with previous publications [13,14], miR-210 was
robustly induced in MCF7 and HCT116 by hypoxia (1% or 0.1%
oxygen) at 24 and 48 hrs, with maximal induction observed at
48 hours in 0.1% oxygen (Figure 1A and Supporting Figure S1A).
ISCU mRNA quantified by RTPCR was inversely correlated to
miR-210 and decreased most significantly when cells were exposed
to more severe hypoxia for longer periods (Figure 1B and
Supporting Figure S1B). Similar to the regulation of miR-210
under hypoxia, ISCU suppression at the transcript level was
dependent on HIF1a and not HIF2a (Supporting Figures S1C
and S1D). Furthermore, the phenomenon of reciprocal regulation
of miR-210 and ISCU by hypoxia was also found in many other
cell lines (Supporting Figures S1E and S1F).
Mimic-210 suppressed ISCU in normoxia and anti-210
reversed the suppression in hypoxia
We recapitulated the observed hypoxic induction of miR-210 by
transfecting MCF7 and HCT116 with mimic-210 in normoxia.
Mimic-210 suppressed ISCU mRNA levels by approximately 60%
(Figure 1C and Supporting Figure S2A). We then antagonised
miR-210 induced under hypoxic conditions with anti-210.
Inhibition of endogenous miR-210 significantly rescued the
suppression of ISCU mRNA, although this was not complete
(Figure 1C and Supporting Figure S2A).
ISCU has two main alternatively spliced isoforms. ISCU1 has
an alternative N-terminal sequence and is localised to the cytosol,
while ISCU2 is associated with the mitochondria. To confirm the
specificity of the antibody used in these studies, MCF7 cells were
treated with siRNAs against ISCU. The band detected in the
control cells was completely suppressed upon transfection with
siISCU1 and siISCU3 (Supporting Figure S2B). The two isoforms
of ISCU could not be distinguished by Western blotting of whole
cell lysates because of the minor difference in molecular weight.
However, the immunoreactive band was detected in both the
cytosolic and mitochondrial fractions (Supporting Figure S2C).
This band is referred to as ISCU protein and its molecular weight
is compatible with the results of Tong et. al. [23].
Under hypoxia, MCF7 and HCT116 cells showed a reduction
in ISCU protein, and this was replicated with mimic-210 in
normoxia (Figure 1D and Supporting Figure S2D). Moreover,
anti-210 partially reversed the hypoxic suppression of ISCU
protein (Figure 1D and Supporting Figure S2D). Hypoxia strongly
suppressed a luciferase reporter containing the 39UTR of ISCU
that included the putative miR-210 target site and this suppression
could be partially rescued by transient transfection of anti-210
(Supporting Figure S2E). In addition, mimic-210 substantially
suppressed the luciferase activity compared to the control in
normoxic MCF7 cells (Supporting Figure S2E). Finally, while
siRNA against ISCU led to a downregulation of both endogenous
ISCU and an exogenous tagged ISCU lacking the 39UTR, mimic-
210 mediated downregulation was only observed on the
endogenous ISCU protein (Supporting Figure S2F). Taken
together, these observations demonstrate that miR-210 downreg-
ulates ISCU mRNA and protein levels by targeting its 39UTR.
Effects of ISCU downregulation on Fe-S proteins
An expected effect of downregulation of ISCU would be a
reduction of Fe-S delivery to target proteins. Therefore we
analysed the impact of ISCU repression on two enzymes that
require Fe-S for their activities, aconitase and mitochondrial
complex I. siRNA against ISCU significantly reduced aconitase
activity in MCF7 and HCT116 cells compared to control cells in
normoxia (Figure 2A). A similar decrease in aconitase activity was
evident in both cell lines upon transfection of mimic-210
(Figure 2A). However there was no change in aconitase protein
levels as assessed by Western blot (Supporting Figure S3A).
Aconitase depleted of Fe-S acts as the translational regulator-
IRP1, to increase uptake of iron. We found the mimic-210
increased iron uptake in HCT116 cells (Supporting Figure S3B).
There was also clear inhibition of mitochondrial complex I activity
induced by mimic-210, in the two cell lines (Figure 2B). In both
cell lines there was down regulation of activity by hypoxia, to a
miR-210 Regulates ISCU
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similar extent to that induced by mimic-210 or by ISCU depletion.
Moreover, transfection of anti-210 in MCF7 cells was able to
significantly increase aconitase activity in hypoxia (Figure 2C).
As the decrease in aconitase and complex I activity reduces the
Krebs cycle and mitochondrial function we investigated whether
there was a shift to glycolysis and lactate production. Our results
showed a highly significant reduction of pyruvate and increase in
lactate in normoxia with the mimic-210, with an increase in lactate
pyruvate ratio. There was also a decrease in lactate production
with the anti-210 in hypoxia (Figure 2D).
Effects of ISCU downregulation on free radical
production
The loss of Fe-S from complex I is likely to affect the transport
of electrons in the electron transport chain and impact on free
radical production. We therefore measured the production of
superoxide in MCF7 and HCT116 cells. In normoxia, both cell
lines showed a marked increase in free radical production upon
transfection of mimic-210 compared to mimic-control (Figure 3A).
In hypoxia we noted a highly significant increase in superoxide
production, which was nearly completely reversed by anti-210
(Figure 3B). Additionally, transfection of the ISCU2 construct
nearly completely reversed the free radical induced by miR-210
(Figure 3C). This demonstrates a major new mechanism for
regulation of ROS in hypoxia, and that it is not a passive effect of
reduced oxygen availability.
Effects of miR-210 on apoptosis and survival in normoxia
and hypoxia
Previous studies in yeast have shown the lethal consequences of
the ISCU homologs deletion [23]. This notion led us to investigate
the effects of miR-210 on apoptosis in normoxia and hypoxia.
There was a striking difference in the effects of mir-210 in these
opposing conditions. In normoxia, mimic-210 substantially
increased apoptosis as measured by annexin V staining, but in
hypoxia, antagonism of miR-210 increased apoptosis (Figure 4A).
To evaluate effects of miR-210 on cell proliferation under
hypoxic conditions, a clonogenic assay was used with a locked
Figure 1. MiR-210 regulates ISCU expression in MCF7 cells. A, miR-210 increases under hypoxia, with the most robust induction seen at 48 hrs
with 0.1% oxygen. B, under the same conditions, the strongest downregulation of ISCU mRNA is observed at 48 hrs with 0.1% oxygen. The expression
levels of miR-210 and ISCU mRNA under hypoxia are relative to their normoxic expression levels at 24 hrs (N). Mean 6 s.e.m. of three independent
experiments is shown (* p,0.05, ** p,0.01, *** p,0.001). C, transfection of anti-210 partially rescues the hypoxic suppression of ISCU mRNA and
mimic-210 overexpression decreases ISCU mRNA in normoxia at 48 hrs. Expression of ISCU mRNA is relative to the anti-ctrl in normoxia (N). Mean 6
s.e.m. of three independent experiments is shown (** p,0.01, *** p,0.001). D, (top panel) ISCU protein is downregulated in MCF7 lysates at 0.1%
oxygen compared to normoxic lysates (N) when the anti-ctrl is transfected for 48 hrs. This decrease in protein level under hypoxic conditions is
partially rescued when the anti-210 is transfected. Under normoxic conditions, mimic-210 suppresses ISCU protein levels compared to mimic-ctrl
transfected cells. D, (bottom panel), quantification of the rescue of ISCU protein level upon transfection of anti-210. Transfection of anti-210 rescues
the ISCU protein levels in MCF7 by approximately 40%. Mean 6 S.E.M of two independent experiments is shown. (* p,0.05).
doi:10.1371/journal.pone.0010345.g001
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nucleic acid antagonist (LNA) miR-210 molecule (Figure 4B).
Although most of the reduction in clonogenicity in hypoxia is
clearly via other mechanisms, the effects of the anti-210 resulted
in decreased clonogenic survival in hypoxia, which we also
found in a more hypoxia-resistant cell line, HeLa cells
(Figure 4C).
In vivo suppression of ISCU by hypoxia and clinical
significance of ISCU expression
We investigated whether expression of ISCU gene expression
was regulated in vivo, by studying human tumour xenografts.
Xenografts of the glioblastoma cell line U87 were treated with
the VEGF inhibitor Avastin (Bevacizumab), or with vehicle
Figure 2. MiR-210 negatively regulates aconitase and complex I activity in MCF7 and HCT116, and upregulates glycolysis. Cells
transfected with siRNA against ISCU or with mimic-210 show a significant decrease in the activity of the Fe-S protein aconitase (A) and complex I (B) at
48 hrs. Activity is expressed relative to scr for siISCU3 or to mimic-ctrl for mimic-210. Mean 6 s.e.m. of three independent experiments is shown
(* p,0.05, ** p,0.01, *** p,0.001). C, hypoxia decreases aconitase and complex I activity in MCF7 and HCT116. Activity is expressed relative to
normoxia (N). Transfection of MCF7 with anti-210 increases the level of aconitase activity, compared to anti-ctrl. Mean 6 s.e.m. of three independent
experiments is shown (* p,0.05, ** p,0.01, *** p,0.001). D, in normoxia, MCF7 transfected with mimic-210 have an increase in the secreted lactate
concentration and a reduction in the extracellular pyruvate after 48 hours. Lactate: Pyruvate ratio shows a significant increase under the same
conditions. Transfection with anti-210 in hypoxia reduced lactate production compared to anti-ctrl transfected cells. Mean6 s.e.m. of three biological
replicates is shown (* p,0.05, ** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0010345.g002
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Figure 3. MiR-210 increases the formation of ROS in MCF7 and HCT116 cell lines. A, in normoxia, transfection of mimic-210 significantly
increases superoxide production at 48 hrs as measured by MitoSox staining. Representative images from mimic-210 transfected cells are shown on
the top panels and the mean6 s.e.m. of approximately 300 cells are shown on the bottom panels (***, p,0.001). B, exposure of cells to 0.1% oxygen
for 48 hrs enhances the production of superoxide; this effect is almost completely reversed upon transfection of anti-210. Representative images
from miR-210 transfected are shown on the left panels and the mean 6 s.e.m. of approximately 300 cells are shown on the right panels
(***, p,0.001). C, ROS production induced by mimic-210 is inhibited in MCF7 cells by cotrasfection with the ISCU2 expressing plasmid. Mean6 s.e.m.
of approximately 300 cells is shown (*** p,0.001). Bars = 10 mm.
doi:10.1371/journal.pone.0010345.g003
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PLoS ONE | www.plosone.org 5 April 2010 | Volume 5 | Issue 4 | e10345
control. Immunohistochemistry of these tumours demonstrated
Avastin-induced necrosis, expression of HIF1a and the HIF
target genes CA9 and VEGF (data not shown). We analysed the
mRNA from the tumours and found marked upregulation of
miR-210 and reciprocal downregulation of ISCU mRNA
(Figure 4D).
The only data available for comparison of miR-210 with ISCU
RNA in human tumour samples is from our breast and head and
neck series. There was a highly significant inverse relationship of
miR-210 to ISCU expression in 216 patients with breast cancer
(rho =20.39, p,0.001) (Figure 5A, left). There was a highly
significant inverse correlation of ISCU with more aggressive high
grade tumours (p = 0.008) and a poor relapse free survival
(Figure 5A, right). In a multivariate analysis, ISCU remained
significant (p = 0.028), along with nodes, grade and age
(Supporting Table S2). In 2 other series of breast cancer
(Rotterdam [26], 286 cases: Uppsala [27]; 235 cases) low ISCU
was a poor prognostic factor in multivariate analysis (Supporting
Tables S3 and S4) (p = 0.038 and 0.015 respectively). In the
Uppsala series [27] we could assess the precursor miR-210 using
the Affymetrix probes (Affymetrix U133b, 230710_at) and this
also showed an inverse relationship of the precursor to ISCU and
poor survival (Figure 5B). In our head and neck cancer series
[25], there was an inverse relationship of these variables
(Figure 5C, left). In a series with published follow up, Chung et
al [28], there was a strong association of suppressed ISCU with
poor outcome (Figure 5C, right). Analysis of expression in normal
tissues versus tumour tissues in 9 tumour data sets using
Oncomine showed in all studies suppression compared to normal
tissues (Supporting Figure S4).
Figure 4. MiR-210 affects cell survival and is inversely correlated to ISCU in hypoxic tumor xenografts. A, apoptosis (Annexin V+ cells)
was measured in MCF7 (left) and HCT116 (right) cells treated with miR-210 inhibitor or mimic, after 48 hours exposure to 0.1% oxygen or normoxia.
Mean 6 s.e.m. is representative of 3 independent experiments (* p,0.05, ** p,0.01, *** p,0.001). B, after transfecting MCF7 cells with scrambled
LNA or mir-210 LNA and exposed to 0.1% oxygen or normoxia (48 hrs), the cells were re-plated (100 and 500 cells/well). After a 12-day incubation,
colonies were fixed, stained, and the surviving fractions were calculated based upon the plating efficiency. C, surviving fractions were calculated as in
(B) in HeLa cells, which were transfected with anti-ctrl or anti-210 (Applied Biosystems/Ambion, Austin, TX, USA) and exposed to 0.01% oxygen or
normoxia. In all colony assays, mean 6 s.e.m. is representative of 2 independent experiments carried out in triplicate employing 2 different plating
densities. (** p,0.01, *** p,0.001). D, RT-PCR for ISCU and miR-210 in U87 xenografts treated with anti-angiogenic therapy (bevacizumab). Relative
expression of ISCU normalised to b-actin, miR-210 normalised to three small nucleolar controls, RNU43, RNU44 and RNU48. Mean expression 6 s.e.m.
in 4 animals/group is shown (** p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0010345.g004
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Discussion
Our studies clearly show miR-210 regulates the expression of
ISCU RNA and protein using the mimic in normoxia in cancer cell
lines. ISCUmRNA and protein were suppressed under hypoxia and
this effect was significantly reversed by anti-210. The incomplete
reversal implies other mechanisms are also involved in ISCU
downregulation and it is well recognised that RNA translation is
reduced by hypoxia via the unfolded protein response [29].
A decrease in ISCU would impair the ability of cells to generate
Fe-S clusters and would subsequently impact on the activity of
enzymes that require these co-factor moieties. We showed that
Figure 5. ISCU suppression is associated to miR-210 over-expression and relapse-free survival in breast cancer and HNSCC. A, miR-
210 qPCR expression (DDCT) plotted as a function of ISCU mRNA expression (Illumina arrays) in the Oxford breast cancer series (left), and, relapse free
survival for samples with high ISCU and low ISCU split by median in the Oxford breast cancer series (right). B, mRNA expression of the transcript
hosting the miR-210 precursor plotted as a function of ISCU mRNA expression measure by Affymetrix U133b and U133a respectively in the Uppsala
breast cancer series (left), and relapse free survival for samples with high ISCU and low ISCU split by median in the Uppsala breast cancer series (right).
C, miR-210 qPCR expression (DDCT) plotted as a function of ISCU mRNA expression (Affymetrix arrays) in the Oxford-Manchester HNSCC cancer series
where ISCU was initially found to be associated to hypoxia (left), and relapse free survival for samples with high ISCU and low ISCU split by median
value in the Chung et al. HNSCC series (right).
doi:10.1371/journal.pone.0010345.g005
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aconitase, a key enzyme of intermediary metabolism that requires
Fe-S clusters, had decreased activity following ISCU reduction. Of
specific relevance to cancer is the dual role of aconitase as IRP1
when it lacks its Fe-S cluster. IRP1 regulates the stability and
translation of mRNA for transferrin and ferritin [24]. The effects
of loss of aconitase would be to modify iron metabolism and
increase its uptake, which is critical for tumour growth. Indeed, we
observed an accumulation of intracellular iron upon transfection
of cells with mimic-210 or siISCU.
Mutations in ISCU give rise to lactic acidosis in individuals after
moderate exercise, providing strong evidence for the importance
of this target in maintaining efficient Krebs cycle activity [30,31].
An associated effect from decreased ISCU levels and subsequent
decrease in the Krebs cycle activity was a switch to glycolysis and
increased lactate production. This was induced in normoxia by
miR-210 and thus is similar to the Warburg effect. This may be
relevant in situations where miR-210 upregulation occurs in
normoxia. For example, this has been shown in renal cancer cell
lines with mutations in the von Hippel Lindau protein [14].
Conversely, in hypoxia, anti-210 reduced lactate production,
reversing the Pasteur effect (switch to glycolysis in hypoxia).
Iron-sulfur clusters are integral for efficient activity of the
mitochondrial electron transport chain. We have shown that
Complex I activity is decreased under hypoxia and upon
transfection of mimic-210 in normoxia. In addition to Complex
I, Complexes II and III also contain Fe-S clusters and we speculate
that the activities of all three complexes could be decreased in a
miR-210 dependent manner. An impaired electron transport
chain would lead to an increase in free radical production as a
consequence of electron leakage. In particular, complex III is a
major contributor to ROS in hypoxia [32] and complex I and II
contribute about 30% of the ROS [33]. In normoxic conditions,
transfection of mimic-210 led to increased free radical production.
Furthermore, the normoxic ROS production observed with
mimic-210 was almost completely prevented with a miR-210
resistant ISCU construct. Conversely, in hypoxia, we observed
that the induction of miR-210 was associated with an increase in
ROS, and this could be almost completely reversed by anti-210.
This provides a major new link to explain the mechanism of ROS
induction in hypoxia, which has been reported by several groups
[33] and may account for the majority of hypoxic ROS induction.
The ROS released in hypoxia have been shown to function as O2
sensors, acting as signalling agents that activate HIF [32], mediate
tumour growth in vivo via a HIF dependent mechanism [5] and
extend lifespan of cells [34].
In contrast to the hypoxic induction of ROS and alleviation
with anti-210 observed in our study, Chan et al. could not measure
any significant change in ROS production after exposure to
hypoxia, and showed an inverted trend when miR-210 was
inhibited [20]. The reason for this discrepancy is unclear but may
potentially reflect an underlying difference in cancer compared to
normal endothelial cells.
Finally, we analysed whether there was any association of ISCU
downregulation in primary human cancers with hypoxia and
outcome, and found an aggressive phenotype was associated with
this change in studies of over 1000 patients, and downregulation
compared to normal tissues in many tumour types.
In conclusion, we have found a major new mechanism for the
response of cancer cells to hypoxia, co-ordinated by miR-210
suppression of ISCU and the subsequent decrease in activity of
iron-sulfur cluster proteins (Supporting Figure S5). In addition to
aconitase, many metabolic enzymes require Fe-S clusters for their
activity suggesting that downregulation of ISCU would have far
reaching consequences on cell metabolism. Mutations in many of
these Fe-S cluster enzymes including succinate dehydrogenase
subunits SDHD, SDHB and SDHC [35] and fumarate hydratase
[36] are implicated in hyperproliferative disorders and cancer,
demonstrating an important link between cellular metabolism and
subsequent transformation and highlights a role for HIF, via a
miR-210-ISCU axis in these processes. In addition to metabolic
enzymes, several DNA repair enzymes [37] with Fe-S clusters are
potentially targets. We have previously shown miR-210 can be
detected at an elevated level in serum of cancer patients [38] so it
will be of interest if they reflect the metabolic state of their primary
cancer and hence could be used in future therapy selection. The
regulation of distinct biological pathways by ISCU downregulation
suggests a potential therapeutic approach of synthetic lethality
whereby drugs that mediate DNA damage repaired by the iron-
sulfur cluster containing helicases Rad3 [39] or Fanconi anaemia
[37] could be use in synergy with PARP inhibitors, or inhibitors of
glycolysis [36] and glutaminolysis in the subgroup of patients with
highest miR-210 levels.
While this work was in preparation, three new miR-210 targets
were validated, i.e. HOXA1, HOXA9 and FGFRL1, and the
analysis of tumour xenografts derived from cancer cell lines
overexpressing miR-210 suggested a potential involvement of
miR-210 in tumour growth initiation [40].
Materials and Methods
Cell culture
Cell exposure to hypoxia (1%, or 0.1%, or 0.01% oxygen) was
undertaken in a hypoxia incubator (MiniGalaxy A, RS Biotech,
Scotland, UK), using a continuous flow of a humidified a mixture
of 95% N2 and 5% CO2.
miRNA mimic or inhibitor transfection
Transfection was performed with Dharmacon anti-210, miR-
210 mimic, or control oligos (Thermo Scientific, CO, USA), at a
final concentration of 20 nM, using Optimem serum-free medium
and Oligofectamine reagent (both from Invitrogen, Paisley, UK) as
per the manufacturer’s protocol.
Transfection and luciferase assays
Luciferase reporter plasmids containing 39 untranslated regions
(UTR) of ISCU or random genomic sequence (control) were
obtained from SwitchGear Genomics (Menlo Park, CA. A Renilla
luciferase expression plasmid (pRL-TK vector, Promega, South-
ampton, UK) was used as transfection control.
Enzyme activity assays
Aconitase activity was using the Bioxytech Aconitase-340 assay
(Oxis International Inc, Beverly Hills, CA). Data are presented as
% of activity compared to control.
Cells were assayed for Complex I activity using the Mitoprofile
Complex I Rapid Elisa Kit (MitoSciences, Eugene, OR, USA)
according to manufacturer’s instructions. Data are presented as %
of activity compared to control.
Lactate and pyruvate measurements
Lactate and pyruvate were assayed using kits from Instruchemie
(Delfzijl, The Netherlands).
MitoSOX staining
Mitochondrial superoxide was assayed using MitoSOX Red
(Molecular Probes, Eugene, OR, USA). Images were acquired
with a confocal microscope (Radiance 2000, Bio-Rad Laborato-
miR-210 Regulates ISCU
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ries, Hemel Hempstead, Herts, UK), and analysed as previously
described [41].
Gene expression data-mining
We previously derived a hypoxia metagene in primary head and
neck cancer squamous cell carcinoma [HNSCC] [25]. Clusters of
genes anti-correlated to miR-210 expression were formed as
described previously [25]; Spearman correlation was used to
identify genes significantly anti-correlated miR-210 and false
discovery rate (FDR) was estimated using a permutation-based
method [42]. Genes with FDR,0.05 were selected. We also used
5 target prediction algorithms:- TargetScanHuman (http://www.
targetscan.org/); Pictar [43]; MiRanda (http://microrna.sanger.
ac.uk/); DianaLab (http://diana.cslab.ece.ntua.gr/), miRDB
(http://mirdb.org/miRDB/).
Survival analyses and other statistical analyses
Spearman correlation was used for continuous variables and
Wilcox test for categorical variables. The Log-Rank test was used
for univariate, and Cox survival was used for multivariate analysis.
Distant-relapse free survival (DRFS) and relapse-free survival
(RFS) were calculated by the STEEP criteria [44]. Statistics were
carried out using non-paired t-tests and significance is represented
by: *, p,0.05, **, p,0.01, and ***, p,0.001.
Supporting Information
Materials and Methods S1
Found at: doi:10.1371/journal.pone.0010345.s001 (0.06 MB
DOC)
Figure S1 Expression of miR-210 and ISCU in cancer cell lines.
(A) In HCT116 cancer cells, miR-210 increases under hypoxia
with the most robust induction seen at 48 hrs with 0.1% oxygen.
(B) Under the same conditions, the strongest downregulation of
ISCU mRNA is observed at 48 hrs with 0.1% oxygen. The
expression levels of miR-210 and ISCU mRNA under hypoxia are
relative to their normoxic expression levels at 24 hrs (N). Mean 6
s.e.m. of three independent experiments is shown. (C, D)
Knockdown of HIF1a but not HIF2a reverses the hypoxic
suppression of ISCU mRNA at 48 hrs in MCF7 and HCT116 cell
lines. Expression of ISCU mRNA is relative to scr in normoxia
(N). Mean 6 s.e.m. of three independent experiments is shown.
(* p,0.05, ** p,0.01, *** p,0.001). (E) A panel of breast can-
cer cell lines were exposed to 1% oxygen for 24 hours (3 rep-
licates/time point). miR-210 expression was measured by qPCR.
Columns show mean fold difference in miR-210 expression
between hypoxia and the parallel normoxia control samples using
RNU48 as a reference; bars show s.e.m.. (F) ISCU was measured
by qPCR comparing normoxia with cells grown in parallel under
1% oxygen; columns show downregulation under hypoxia, bars
show s.e.m.
Found at: doi:10.1371/journal.pone.0010345.s002 (1.01 MB TIF)
Figure S2 ISCU expression is regulated by miR-210. (A)
Transfection of anti-210 partially rescues the hypoxic suppression
of ISCU mRNA and mimic-210 overexpression decreases ISCU
mRNA in HCT116 cells in normoxia at 48 hrs. Expression of
ISCU mRNA is relative to the anti-ctrl in normoxia (N). Mean 6
s.e.m. of two independent experiments for HCT116 is shown.
(* p,0.05, ** p,0.01, *** p,0.001). (B) MCF7 cells were
transfected with two siRNA against ISCU, siISCU1 and siISCU3.
The ISCU protein normally seen under normoxic conditions is
completely downregulated with both siRNAs. (C) Cellular
subfractionation shows that mimic-210 downregulates both
mitochondrial and cytosolic ISCU isoforms. Immunoblotting
against Tom20 (Santa Cruz Biotechnologies, CA, USA) and actin
were used as loading control of the mitochondrial and cytosolic
compartment respectively. Cellular subfractionation was per-
formed in MCF7 cells using the Mitochondrial Isolation Kit for
cells in Culture (Thermofisher, CO, USA). (D, top panel) ISCU
protein is downregulated in HCT116 lysates at 0.1% oxygen
compared to normoxic lysates (N) when the anti-ctrl is transfected
for 48 hrs. This decrease is partially rescued when the anti-210 is
transfected. Under normoxic conditions, mimic-210 suppresses
ISCU protein levels compared to mimic-ctrl transfected cells. (D,
bottom panel) Quantification of the rescue of ISCU protein level
upon transfection of anti-210. Transfection of anti-210 rescues the
ISCU protein levels in HCT116 by approximately 40%. Mean 6
S.E.M of two independent experiments is shown. (* p,0.05). (E)
The 39-UTR is required for the regulation of ISCU by miR-210.
A luciferase reporter construct containing the full length 39-UTR
of ISCU or random sequence (Ctrl-39-UTR) was co-transfected
with 20 nM of mimic-210/mimic-ctrl or 40 nM of anti-210/anti-
ctrl in MCF7 cells. The cotransfection of a vector expressing
Renilla luciferase was used to normalize for transfection efficiency.
The luciferase activity was expressed as a ratio of ISCU-39-UTR
to ctrl-39-UTR relative to expression in normoxia. All experiments
were carried out in triplicate, (n = 9); error bars denote the
standard deviation. (***p,0.001). (F) MCF7 and HCT116 cells
were transfected with an expression plasmid for a Myc-DKK
tagged ISCU2 lacking the 39-UTR. Subsequent transfection of
siISCU3 reduced the protein levels of both endogenous and
exogenous ISCU. Mimic-210 only affected the endogenous ISCU
protein level.
Found at: doi:10.1371/journal.pone.0010345.s003 (1.01 MB TIF)
Figure S3 Iron uptake assessed by ferric iron staining.
Knockdown of ISCU with siISCU3 led to an accumulation of
ferric iron compared to control siRNA transfected HCT116 cells.
This effect was reproduced when cells were transfected with
mimic-210 compared to mimic-ctrl. HCT116 cells were trans-
fected as described above and treated with 100 mg/L Ferric
Ammonium Citrate for 16 hours. The cells were then fixed and
stained with 4% Formalin and Perl’s solution (1% K4Fe(CN)6 and
1% HCl) for 30 minutes at room temperature. Cells were then
incubated with 0.75 mg/ml diaminobenzidine (DAB), H2O2 in
1 M Tris pH 7.5 for 60 minutes. The reaction was then completed
by washing the cells in PBS. Original magnification: 1006.
Found at: doi:10.1371/journal.pone.0010345.s004 (1.19 MB TIF)
Figure S4 Oncomine data. The Oncomine website (Oncomi-
ne.org) was searched for microarrays containing the gene ISCU.
When compared to normal tissue, ISCU was significantly
downregulated in 9 tumour microarray experiments; data for
relative expression units, normalised to median z-score to enable
comparison across multiple studies, were downloaded and
graphed. p,0.05 for all, Student’s t-test.
Found at: doi:10.1371/journal.pone.0010345.s005 (0.97 MB TIF)
Figure S5 Hypoxia regulates ISCU via HIF1a induction of
miR-210. miR-210 represses ISCU 39-UTR and reduces ISCU
protein. Reduced Fe-S assembly in the mitochondrial electron
transport chain results in inhibition of major sites of electron
transfer. This is a key mechanism for generating ROS, which have
both positive and negative effects in hypoxia. Reduction of
aconitase activity inhibits the Krebs cycle, resulting in an increase
in glycolysis and lactate production. Aconitase 1 (cytosolic
aconitase) when depleted of Fe-S becomes an iron regulatory
protein, irp1, binding to iron response elements in the 39-UTR of
the transferrin receptor. This stabilises the mRNA increasing
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transcription and enhancing iron uptake. Other Fe-S proteins are
potential targets.
Found at: doi:10.1371/journal.pone.0010345.s006 (0.60 MB TIF)
Table S1 Top predicted mir-210 targets using tumour data plus
algorithms.
Found at: doi:10.1371/journal.pone.0010345.s007 (0.05 MB
DOC)
Table S2 Multivariate analysis of ISCU expression and relapse
free survival in the Oxford: breast cancer series [14] (N=216).
Found at: doi:10.1371/journal.pone.0010345.s008 (0.05 MB
DOC)
Table S3 Multivariate analysis of mRNA ISCU expression and
disease-specific survival in the Uppsala breast cancer series
published series [27] (N= 235).
Found at: doi:10.1371/journal.pone.0010345.s009 (0.05 MB
DOC)
Table S4 Multivariate analysis of ISCU expression and relapse
free survival in the Rotterdam series of lymph-node-negative
primary breast cancer [26] (N=286).
Found at: doi:10.1371/journal.pone.0010345.s010 (0.05 MB
DOC)
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